HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo Changes Reporting Structure In Latest Stop On Cost-Cutting Trail

This article was originally published in The Pink Sheet

Executive Summary

Perrigo reorganizes its reporting segments to better align with its organizational structure; consumer product units are combined and renamed.

You may also be interested in...



Perrigo Starts Branded Consumer Product Rescue Mission In Belgium

Perrigo is restructuring its OTC drug and nutritional product businesses in Belgium – Omega Pharma Belgium NV, Etixx NV and Biover NV – and expects changes will eliminate between 45 and 80 jobs.

Perrigo Puts Tysabri On Block, Generic Topicals Under Microscope

A portfolio review concluded that 'the next step to unlock shareholder value is … exploring strategic alternatives for that Tysabri royalty stream,' CEO John Hendrickson said during Perrigo's third-quarter earnings briefing.

Perrigo Plays To OTC Strength With GoodSense Firm Acquisition

Geiss, Destin & Dunn's GoodSense brand includes more than 1,500 OTC drugs and nutritional products. The deal could help diminish the impact of earnings headwinds on Perrigo's branded consumer health and Rx generic topicals businesses.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS122857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel